Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
批准号:
9419367
负责人:
Andrew Patterson
金额:
$15.72万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-01 至 2019-02-28
关键词:
AddressAdultAlbuminsAroclor 1254Aryl Hydrocarbon ReceptorAutomobile DrivingBiologyCeramidesCommunitiesConsultDataDependenceDevelopmentDietDioxinsDiscipline of NursingDisease OutcomeDoseElectrophoretic Mobility Shift AssayEnvironmental PollutantsEnvironmental PollutionExperimental DesignsExposure toFatty LiverFutureGenesGenomicsGerm-FreeGnotobioticHepaticHumanInflammationInflammatoryIntestinesKnock-outLCN2 geneLigandsLinkLiverMeasurementMediatingMetabolicMetabolic DiseasesMetagenomicsMolecular ToxicologyMusNursesObesityPathogenesisPathway interactionsPlayPolychlorinated BiphenylsPopulationPredispositionProductionPublishingReceptor ActivationRepressionResearchResearch PersonnelRoleSequence AnalysisSpecificityTechniquesTetrachlorodibenzodioxinTimeTissuesToxicologyWeaningaryl hydrocarbon receptor ligandchromatin immunoprecipitationcytokineexperimental studyflexibilitygut microbiomegut microbiotainnovationinsightinterestlipid biosynthesisliver developmentmetabolic phenotypemetabolomicsmicrobiomemid-career facultymouse modelnon-alcoholic fatty livernovelprogramsrRNA Genesresponsevillin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The scientific community is increasingly appreciative of the important role the aryl hydrocarbon receptor (AHR)
plays in modulating the host-microbiome metabolic axis. Interestingly, there are strong links between the gut
microbiota and the development and/or exacerbation of nonalcoholic fatty liver disease (NAFLD), all of which
are modulated by activation or repression of the AHR. At present, however, a direct connection between AHR
activation, changes in gut microbiota composition, ceramide synthesis, and NAFLD development has not been
established. Further the concept that environmental pollutant-mediated disruption and/or modulation of the
AHR-gut microbiota metabolic axis leads to the development of NAFLD has not been addressed. Our
published and preliminary data with 2,3,7,8-tetrachlorodibenzofuran (TCDF) indicates AHR activation
profoundly alters the gut microbiota in a qualitative and quantitative manner, increases hepatic lipogenesis,
and significantly alters hepatic ceramide synthesis through direct AHR activity (a proposed driver of NAFLD).
These results have led us to the novel central hypothesis: Dietary exposure to potent environmental AHR
ligands leads to functionally significant changes in the gut microbiota that exacerbate NAFLD in a
time- and Ahr-dependent manner.
Through the innovative use of cutting-edge techniques (metagenomics and metabolomics) and unique mouse
models (tissue specific knockouts of Ahr, gnotobiotic mice, and fecal transfer experiments), we plan to identify
the functional changes imparted to the gut microbiota following dietary exposure to potent AHR ligands such as
TCDF and to evaluate the Ahr-dependent role of ceramides in driving NAFLD pathogenesis and progression.
This combination of approaches will allow us to accurately assess bacterial phyla dynamics and its interaction
with and impact on the host, and whether these changes result in increased susceptibility to NAFLD. We are
particularly interested in how the timing (weaning and adulthood) of the exposure influences disease outcome.
This study will provide invaluable insight into the effects of exposure on a number of environmentally relevant
persistent AHR ligands, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and co-planar PCBs and provide
valuable endpoints for future studies in human populations.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Environmental Chemical Impact on the Host-Microbiome Interaction
-
批准号:10641509
-
项目类别:
-
资助金额:$93.15万
-
财政年份:2023
-
负责人:Andrew Patterson
-
依托单位:
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
-
批准号:10417044
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2020
-
负责人:Andrew Patterson
-
依托单位:
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
-
批准号:10626745
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2020
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10311068
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10066327
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:9906573
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10228735
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10539245
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10488612
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10671560
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10022323
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9753729
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9982685
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:10217133
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8545853
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8416524
-
项目类别:
-
资助金额:$47.86万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8914846
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8857440
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:9066662
-
项目类别:
-
资助金额:$25.78万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8687654
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
海外基金